Life Science Compliance Update

July 27, 2015

Sixteenth Pharmaceutical Compliance Congress and Best Practices Forum

16th Compliance

The sixteenth annual Pharmaceutical and Regulatory Compliance Congress will take place October 21-23 at the Mandarin Oriental in Washington, DC. The three-day conference features an impressive array of expert speakers and faculty from regulatory agencies, the pharmaceutical industry, and law firms.

Click here for the Conference website link.

The Keynote Speakers this year include:

  • Thomas W. Abrams, RPh, MBA
    Director, Office of Prescription Drug Promotion, Food and Drug Administration

  • Robert Barrington, PhD
    Executive Director, Transparency International-UK

  • Douglas Brown
    Deputy Director, Data Sharing & Partnership Group, Center for Program Integrity, Centers for Medicare and Medicaid Services, US Department of Health and Human Services

  • Benjamin C. Mizer, Esq.
    Principal Deputy Assistant Attorney General, Civil Division, Former Counselor to Attorney General Eric H. Holder, Jr., US Department of Justice

  • Mary E. Riordan, Esq.
    Senior Counsel, Office of Counsel to the Inspector General, Office of Inspector General, US Department of Health and Human Services

Last year's conference featured many interesting sessions in addition to the updates from various government agencies, including a qui tam panel, compliance officer round-table, and Sunshine Act best practices update.

Registration is available here

June 11, 2015

CBI 9th Annual Forum on Transparency & Aggregate Spend Features Comprehensive Update of Open Payments

The 9th Annual Forum on Transparency & Aggregate Spend is the best attended and longest running transparency meeting providing the most up-to-date and robust intelligence available on how to streamline transparency reporting and use data analytics to improve compliance and commercial programs. The event will be August 17-19, 2015 in Washington, D.C.

On Wednesday, August 19, Thomas Sullivan, President of Rockpointe and Editor of Policy and Medicine will be presenting "Recent Publication and Media Portrayal of 2014 Open Payments Data".

At the Forum, attendees will learn more about:

  • The Latest CMS Changes on Open Payments for 2016 Reporting
  • Standardize Your Process for Remediation and Data Attestation to Mitigate Risk
  • Unravel the Complexities of Travel Reimbursement Policies and Reporting
  • Update on State Disclosure Laws —
    Preemption, Enforcement and Continued Reporting Requirements
  • Benefit from Hearing a Summary of Common Disputes and How They've Been Resolved — Featuring the Physician's Perspective
  • Live Benchmarking with Colleagues —
    See the Comparison with Survey Results Over the Last Three Years

Attendees will benefit from attending this event if you are CFO, CAO, Controller or senior-level director from the pharmaceutical or biotech industries with responsibilities or involvement in the following areas, including transparency, aggregate spend, reporting, compliance, legal, regulatory, finance/accounting, commercial operations, medical affairs, and more.

Download a brochure here.

Register here for the event. Pricing and more information about the venue can be found here. Policy and Medicine Readers Qualify for a $400* Savings by typing in the code AGGPOL by 6/19/2015

Current advantage pricing rates expires on June 19, 2015.

*Discount ends 6/19/2015; applies to standard rates only and may not be combined with other offers, category rates, and promotions or applied to an existing registration.

Newsletter


Preview | Powered by FeedBlitz

Search


 
Sponsors
July 2015
Sun Mon Tue Wed Thu Fri Sat
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31